Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corticotropin-releasing factor type‑I receptor (CRF1) is a class B GPCR essential for mediating neuroendocrine responses to stress through activation by its ligands—primarily corticotropin-releasing hormone—and subsequent stimulation of intracellular cAMP signaling pathways. It plays a pivotal role both developmentally and physiologically within systems governing homeostasis and behavioral adaptation under stressful conditions. Its dysfunction has broad implications for mental health disorders related to abnormal HPA axis activity.
Agonism or antagonism of CRH/UCN binding, modulation of cAMP/PKA signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-Releasing Factor Type-1 Receptor (CRF1).